These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20880829)

  • 1. Prolonged catatonic stupor successfully treated with aripiprazole in an adolescent male with schizophrenia: a case report.
    Kirino E
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):185-8. PubMed ID: 20880829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.
    Hori H; Yoshimura R; Katsuki A; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    J Psychiatr Res; 2012 Jun; 46(6):757-61. PubMed ID: 22464338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of aripiprazole in the treatment of catatonia].
    Vörös V; Tényi T
    Neuropsychopharmacol Hung; 2010 Jun; 12(2):373-6. PubMed ID: 20606247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
    Stip E; Tourjman V
    Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of intramuscular aripiprazole injection in patients with catatonia: report on three cases.
    Voros V; Kovacs A; Herold R; Osvath P; Simon M; Fekete S; Tenyi T
    Pharmacopsychiatry; 2009 Nov; 42(6):286-7. PubMed ID: 19924590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of aripiprazole in early onset schizophrenia: safety and efficacy.
    Normala I; Hamidin A
    Med J Malaysia; 2009 Sep; 64(3):240-1. PubMed ID: 20527278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia.
    Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S
    Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stable patient with schizophrenia--from antipsychotic effectiveness to adherence.
    Thomas P
    Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S115-22. PubMed ID: 17336766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of schizoaffective disorder with ritualistic behaviors and catatonic stupor: successful treatment by risperidone and modified electroconvulsive therapy.
    Bai Y; Yang X; Zeng Z; Yang H
    BMC Psychiatry; 2018 Mar; 18(1):67. PubMed ID: 29534691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism.
    Naber D; Lambert M
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1213-9. PubMed ID: 15588748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of switching to risperidone after unsuccessful treatment with aripiprazole on plasma monoamine metabolites level in the treatment of acute schizophrenia.
    Miura I; Takeuchi S; Katsumi A; Kanno K; Watanabe K; Mashiko H; Niwa S
    Hum Psychopharmacol; 2012 Sep; 27(5):517-20. PubMed ID: 22927115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine.
    Kane JM; Meltzer HY; Carson WH; McQuade RD; Marcus RN; Sanchez R;
    J Clin Psychiatry; 2007 Feb; 68(2):213-23. PubMed ID: 17335319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aripiprazole: a review of its pharmacology and clinical use.
    Taylor DM
    Int J Clin Pract; 2003; 57(1):49-54. PubMed ID: 12587943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in schizophrenia: consensus guidelines.
    Travis MJ; Burns T; Dursun S; Fahy T; Frangou S; Gray R; Haddad PM; Hunter R; Taylor DM; Young AH
    Int J Clin Pract; 2005 Apr; 59(4):485-95. PubMed ID: 15853869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aripiprazole for the treatment of schizophrenia with co-occurring social anxiety: an open-label cross-taper study.
    Stern RG; Petti TA; Bopp K; Tobia A
    J Clin Psychopharmacol; 2009 Jun; 29(3):206-9. PubMed ID: 19440071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia.
    Sokolski KN
    Ann Pharmacother; 2011 Jul; 45(7-8):e36. PubMed ID: 21672885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.